NCT00891137 2014-10-27Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCellerant TherapeuticsPhase 1 Completed30 enrolled
NCT01500161 2013-11-25Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTexas Oncology Cancer CenterPhase 2 Terminated1 enrolled
NCT00195533 2009-11-16Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic PatientsWyeth is now a wholly owned subsidiary of PfizerCompleted801 enrolled
NCT00095277 2009-03-13Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of CancerAmgenPhase 2 Completed220 enrolled